Work

Monoclonal Antibody and Liposomal Nanoparticle-based Targeting Therapies for Chronic Lymphocytic Leukemia

Year: 2012
Type: article
Abstract: Chronic Lymphocytic Leukemia (CLL), representing 30% of leukemia, remains the most common hematologic malignancy in the western world.It is diagnosed by peripheral blood immunophenotyping with co-expression of biomarkers, such as CD5, CD19, CD20 and CD23, on B cell surface and with more than 5,000 B lymphocytes in one μl.The first-line treatment for CLL includes monotherapy or combined chemotherapy of alkylating agents (e.g.chlorambucil and cyclophosphamide), purine analogues (e.g.fludarabine and cladribine) and monoclonal antibody based immunotherapy (e.g.rituximab and alemtuzumab) CD20 directed therapeutic antibodies such as rituximab and ofatumumab are widely used in CLL therapy.However, there are still limitations of currently existing first-line treatments for CLL due to nonspecific cytotoxicity induced by drug or relapse caused by immunotherapy.Therefore, it is crucial to develop therapies that are efficiently and specifically targeting to the malignant B-CLL cells.Herein, we explore monoclonal antibody (mAb) and liposomal nanoparticles-based therapeutic strategies for CLL with the goal to achieve efficient and directed drug/gene delivery with minimal side effects.Firstly, a relatively new antibody, anti-CD37, was combined with one of the two classical antibodies, anti-CD19 or anti-CD20 to form dual-ligand immunoliposome Reduction in hCD20+ cells from bone marrow of Raji xenograft mice………………………………………………….………..……… Cytokine level in plasma of mice from Raji xenograft model……… Changes in induced co-stimulatory molecule CD86 in human CD19+ cells from bone marrow cells from Raji xenograft model……………… Summary of main contributions in this work………………………….….Cryogenic-transmission electron microscopy (cryo-TEM) images of structures of lipoplex nanoparticles prepared by the bulk mixing method…………………………………………………………………... Structures of multifunctional liposomal nanoparticles in several fractions after centrifugation……………………………………………..………….
Author: Yicheng Mao
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: green
OpenAlex ID: W2522534979
FWCI:
Cites: 102
Cited by: 1
Related to: 10